EP1325120A4 - Neue nukleinsäuren und polypeptide - Google Patents

Neue nukleinsäuren und polypeptide

Info

Publication number
EP1325120A4
EP1325120A4 EP01977088A EP01977088A EP1325120A4 EP 1325120 A4 EP1325120 A4 EP 1325120A4 EP 01977088 A EP01977088 A EP 01977088A EP 01977088 A EP01977088 A EP 01977088A EP 1325120 A4 EP1325120 A4 EP 1325120A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01977088A
Other languages
English (en)
French (fr)
Other versions
EP1325120A2 (de
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1325120A2 publication Critical patent/EP1325120A2/de
Publication of EP1325120A4 publication Critical patent/EP1325120A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01977088A 2000-10-12 2001-10-11 Neue nukleinsäuren und polypeptide Withdrawn EP1325120A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68752700A 2000-10-12 2000-10-12
US687527 2000-10-12
PCT/US2001/027760 WO2002031111A2 (en) 2000-10-12 2001-10-11 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1325120A2 EP1325120A2 (de) 2003-07-09
EP1325120A4 true EP1325120A4 (de) 2005-05-25

Family

ID=24760764

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01977088A Withdrawn EP1325120A4 (de) 2000-10-12 2001-10-11 Neue nukleinsäuren und polypeptide

Country Status (4)

Country Link
EP (1) EP1325120A4 (de)
AU (1) AU2001296235A1 (de)
CA (1) CA2425827A1 (de)
WO (1) WO2002031111A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (de) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
EP1228085A4 (de) * 1999-11-05 2005-02-02 Gen Hospital Corp Ein 'gridlock'-nukleinsäuremolekül, polypeptide, und diagnostische und therapeutische verfahren
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
ES2304126T3 (es) 2000-01-26 2008-09-16 Agensys, Inc. 84p2a9: una proteina especifica de prostata y testiculos altamente expresada en el cancer de prostata.
AU2001271621A1 (en) 2000-06-28 2002-01-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
JP2002034565A (ja) 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
EP1332153A4 (de) * 2000-10-12 2006-01-11 Exelixis Inc Humanes ect2 und verfahren zu dessen verwendung
WO2002036763A1 (fr) * 2000-10-30 2002-05-10 Takeda Chemical Industries, Ltd. Nouveau gene surexprime dans le coeur et les muscles et son utilisation
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
US7153678B2 (en) 2000-12-20 2006-12-26 Bristol-Myers Squibb Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
WO2002062839A2 (en) * 2001-02-07 2002-08-15 Universiteit Maastricht Markers of unstable atherosclerotic plaques
PT1434592E (pt) * 2001-04-10 2009-02-25 Agensys Inc Ácido nucleico e correspondente proteína intitulada 121p2a3 úteis no tratamento e detecção de cancro
JP2004528046A (ja) * 2001-06-05 2004-09-16 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＤＧＫｓおよび使用方法
WO2003004989A2 (en) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
JP2003024080A (ja) * 2001-07-19 2003-01-28 Univ Tokyo ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
AU2003281314A1 (en) * 2002-07-09 2004-01-23 Takeda Pharmaceutical Company Limited Nove protein and use thereof
JP4301541B2 (ja) * 2002-09-05 2009-07-22 独立行政法人科学技術振興機構 Ｓｍｇ−１結合タンパク質及びその活性を制御する物質のスクリーニング方法
AU2003276874B2 (en) * 2002-09-11 2009-09-03 Genentech, Inc. Novel compositions and methods for the treatment of immune related diseases
EP1604033A2 (de) * 2002-11-08 2005-12-14 Bayer HealthCare AG Diagnostika und therapeutika für krankheiten, die mit humanen phosphodiesterase 11a3 (pde11a3) assoziiert sind
AU2003901055A0 (en) * 2003-02-17 2003-03-20 Nathan E Hall Methods for inhibiting signal transduction
EP1627051A4 (de) * 2003-05-07 2006-09-06 Univ Massachusetts Regulation der acheronexpression
US20050026194A1 (en) * 2003-06-20 2005-02-03 Tularik Inc. Gene amplification and overexpression in cancer
WO2005014817A2 (en) * 2003-08-07 2005-02-17 Compugen Ltd. Chordin-like homologs
CN1898260A (zh) * 2003-10-28 2007-01-17 普罗特米克斯发现有限公司 具有抗肥胖活性的肽及其它相关应用
WO2005075641A1 (ja) 2004-02-09 2005-08-18 Eisai R & D Management Co., Ltd. スクリーニング方法
JP2007522791A (ja) * 2004-02-24 2007-08-16 オンコセラピー・サイエンス株式会社 結腸直腸癌を診断する方法
DE602005023021D1 (de) * 2004-06-02 2010-09-30 Tss Biotech Inc Neues polypeptid mit eignung zur diagnose und behandlung von krebs
BRPI0514395A (pt) 2004-08-16 2008-06-10 Quark Biotech Inc uso terapêutico de inibidores de rtp801
US7531634B2 (en) * 2004-12-03 2009-05-12 University Of Pittsburgh Bladder matrix protein peptides and methods of detection of bladder cancer
EP1856278A2 (de) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Verfahren zur diagnose von blasenkrebs
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
JP4961595B2 (ja) * 2005-04-25 2012-06-27 国立大学法人山梨大学 Ｃｌｅｃ−２シグナル伝達により止血疾患を治療するための組成物および方法
NL2000439C2 (nl) 2006-01-20 2009-03-16 Quark Biotech Therapeutische toepassingen van inhibitoren van RTP801.
US7723052B2 (en) 2006-05-11 2010-05-25 Quark Pharmaceuticals, Inc. Screening systems utilizing RTP801
EP2026843A4 (de) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Therapeutische verwendungen von rtp801l
SG10201502098YA (en) 2006-10-17 2015-05-28 Oncotherapy Science Inc Peptide Vaccines For Cancers Expressing MPHOSPH1 OR DEPDC1 Polypeptides
EP2137205A2 (de) 2007-02-26 2009-12-30 Quark Pharmaceuticals, Inc. Inhibitoren von rtp801 und ihre verwendung bei der behandlung von krankheiten
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
KR20110044764A (ko) * 2008-07-28 2011-04-29 이데라 파마슈티칼즈, 인코포레이티드 안티센스 올리고누클레오티드에 의한 톨-유사 수용체 9 발현의 조절
EP2362904B1 (de) 2008-08-28 2016-11-16 Oncotherapy Science, Inc. Verfahren zum screenen von verbindungen zur verwendung bei der hemmung der depdc1 - znf224 bindung
PT2408913T (pt) 2009-03-18 2017-03-07 Oncotherapy Science Inc Péptidos neil3 e vacinas que incluem os mesmos
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
GB201009654D0 (en) * 2010-06-09 2010-07-21 Cancer Res Technology Nucleic acid methyltransferase
US8962587B2 (en) * 2011-08-31 2015-02-24 Taipei Veterans General Hospital Gene delivery of OCT4 and SirT1 and pharmaceutical compositions thereof
US10653782B2 (en) * 2014-11-25 2020-05-19 Nortwestern University Retroviral particles expressing Sirt1 embedded within PPCN
CN108138170B (zh) 2015-08-12 2022-01-25 肿瘤疗法科学股份有限公司 Depdc1衍生的肽和包含它们的疫苗

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 October 1998 (1998-10-01), XP002307625, retrieved from EBI Database accession no. AI148629 *
DATABASE EMBL [online] 22 May 2001 (2001-05-22), NI ET AL., XP002307627, retrieved from EBI Database accession no. AAF91870 *
DATABASE EMBL [online] 3 March 2000 (2000-03-03), ZHANG ET AL., XP002307624, retrieved from EBI Database accession no. AF151068 *
DATABASE GENSEQ [online] 27 August 2002 (2002-08-27), ROSEN ET AL., XP002307628, retrieved from EBI Database accession no. ABG65339 *
DATABASE GENSEQ 22 May 2001 (2001-05-22), NI ET AL., XP002307626, retrieved from EBI Database accession no. AAB87354 *
See also references of WO0231111A3 *
ZHANG ET AL: "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoetic stem/progenitor cells", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 10, no. 10, October 2000 (2000-10-01), pages 1546 - 1560, XP002215896, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
AU2001296235A1 (en) 2002-04-22
WO2002031111A3 (en) 2002-10-17
WO2002031111A2 (en) 2002-04-18
CA2425827A1 (en) 2002-04-18
EP1325120A2 (de) 2003-07-09

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (de) Neue nukleinsäuren und polypeptide
EP1341804A4 (de) Neue nukleinsäuren und polypeptide
EP1504099A4 (de) Neue nukleinsäuren und polypeptide
EP1381621A4 (de) Neue nukleinsäuren und polypeptide
EP1432800A4 (de) Neue nukleinsäuren und polypeptide
EP1470238A4 (de) Neue nukleinsäuren und polypeptide
EP1242443A4 (de) Neue nukleinsäuren und polypeptide
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1430112A4 (de) Neue nukleinsäuren und polypeptide
EP1276751A4 (de) Neue nukleinsäuren und polypeptide
EP1368475A4 (de) Neue nukleinsäuren und polypeptide
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
EP1341803A4 (de) Neue nukleinsäuren und polypeptide
AU2001263005A8 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030415

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050406

17Q First examination report despatched

Effective date: 20050524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050928